Chief Scientific Officer and CEO
Drug delivery technology
United States of America
Dr. Au received her Pharm.D. and Ph.D. degrees from University of California San Francisco and postdoctoral training at Roswell Park Cancer Institute. Dr. Au is recognized for her accomplishments in pharmaceutical and cancer research. Her breadth of interests and training in both clinical and basic sciences have allowed her to excel in translating her laboratory discoveries in cellular and molecular pharmacology of anticancer drugs into clinical applications. Dr. Au is among the top 5% recipients of NIH funding over 25 years.
Linking academic discoveries with commercial applications, cancer research and patients